Evidence map›Paper›PMID 34799698›Full record

ArticleNature metabolism2021

The metabolic growth limitations of petite cells lacking the mitochondrial genome.

Jakob Vowinckel, Johannes Hartl, Hans Marx, Martin Kerick, Kathrin Runggatscher, Markus A Keller, Michael Mülleder, Jason Day, Manuela Weber, Mark Rinnerthaler and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. OverlookedbioRxiv : the preprint server for biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 7 countries.

Jakob Vowinckel *Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
Johannes Hartl *Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-8470-5355
Hans MarxDepartment of Biotechnology, University of Natural Resources and Life Sciences Vienna, Vienna, Austria.
Martin KerickSequencing Core Facility, Max Planck Institute for Molecular Genetics and Max Planck Unit for the Science of Pathogens, Berlin, Germany.ORCID http://orcid.org/0000-0002-6298-4514
Kathrin RunggatscherDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
Markus A KellerDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
Michael MüllederDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
Jason DayDepartment of Earth Sciences, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-3078-0963
Manuela WeberDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Mark RinnerthalerDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID http://orcid.org/0000-0003-1190-0584
Jason S L YuThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.
Simran Kaur AulakhThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.
Andrea LehmannCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Biochemistry, Berlin, Germany.
Diethard MattanovichDepartment of Biotechnology, University of Natural Resources and Life Sciences Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-0907-4167
Bernd TimmermannSequencing Core Facility, Max Planck Institute for Molecular Genetics and Max Planck Unit for the Science of Pathogens, Berlin, Germany.
Nianshu ZhangDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
Cory D DunnInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-2393-5944
James I MacRaeMetabolomics Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1464-8583
Michael BreitenbachDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Markus RalserDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK. markus.ralser@crick.ac.uk.ORCID http://orcid.org/0000-0001-9535-7413
University of Cambridge · GBThe Francis Crick Institute · GBUniversity of Salzburg · ATBOKU University · ATMax Planck Institute for Molecular Genetics · DEHumboldt-Universität zu Berlin · DEInnsbruck Medical University · ATUniversity of Helsinki · FI

Funding

Austrian Science Fund FWF P 26713Cancer Research UK FC001134European Research Council 260809Wellcome Trust 200829Wellcome Trust FC001134
6 · The paper itself

Abstract

Eukaryotic cells can survive the loss of their mitochondrial genome, but consequently suffer from severe growth defects. 'Petite yeasts', characterized by mitochondrial genome loss, are instrumental for studying mitochondrial function and physiology. However, the molecular cause of their reduced growth rate remains an open question. Here we show that petite cells suffer from an insufficient capacity to synthesize glutamate, glutamine, leucine and arginine, negatively impacting their growth. Using a combination of molecular genetics and omics approaches, we demonstrate the evolution of fast growth overcomes these amino acid deficiencies, by alleviating a perturbation in mitochondrial iron metabolism and by restoring a defect in the mitochondrial tricarboxylic acid cycle, caused by aconitase inhibition. Our results hence explain the slow growth of mitochondrial genome-deficient cells with a partial auxotrophy in four amino acids that results from distorted iron metabolism and an inhibited tricarboxylic acid cycle.

Indexed as

Energy MetabolismGenome, MitochondrialAmino AcidsBiomassCell ProliferationCitric Acid CycleFungal ProteinsMembrane Potential, MitochondrialMitochondriaMutationPhenotypeStructure-Activity RelationshipYeastsAmino AcidsFungal Proteins

Identifiers

PMID34799698
PMCPMC7612105
OpenAlexW3211868415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.